Related references
Note: Only part of the references are listed.Prostate cancer polygenic risk score and prediction of lethal prostate cancer
Robert J. Klein et al.
NPJ PRECISION ONCOLOGY (2022)
Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk
Weiqiang Li et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis
Zhuqing Shi et al.
EUROPEAN UROLOGY (2021)
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Minh-Phuong Huynh-Le et al.
NATURE COMMUNICATIONS (2021)
Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk
Burcu F. Darst et al.
EUROPEAN UROLOGY (2021)
Incorporation of Polygenic Risk Score into Guidelines for Inherited Risk Assessment for Prostate Cancer
Jianfeng Xu et al.
EUROPEAN UROLOGY (2021)
Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort
Jun Wei et al.
PROSTATE (2021)
Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?
Ana R. Pinto et al.
PHARMACOGENOMICS (2020)
Tutorial: a guide to performing polygenic risk score analyses
Shing Wan Choi et al.
NATURE PROTOCOLS (2020)
Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth
Guillermo Lorenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer
Yishuo Wu et al.
PROSTATE (2018)
Germline mutations in PPFIBP2 are associated with lethal prostate cancer
Yishuo Wu et al.
PROSTATE (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
Julius Gudmundsson et al.
NATURE COMMUNICATIONS (2018)
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Rong Na et al.
EUROPEAN UROLOGY (2017)
Fast Principal-Component Analysis Reveals Convergent Evolution of ADH1B in Europe and East Asia
Kevin J. Galinsky et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Prostate cancer: measuring PSA
C. Pezaro et al.
INTERNAL MEDICINE JOURNAL (2014)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
OPINION The link between benign prostatic hyperplasia and prostate cancer
David D. Orsted et al.
NATURE REVIEWS UROLOGY (2013)
Recommendations for presenting analyses of effect modification and interaction
Mirjam J. Knol et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men
David D. Orsted et al.
EUROPEAN UROLOGY (2011)
Smaller Prostate Size Predicts High Grade Prostate Cancer at Final Pathology
Mark R. Newton et al.
JOURNAL OF UROLOGY (2010)
Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
Jiyoung Ahn et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prostate volume and adverse prostate cancer features: Fact not artifact
Alberto Briyanti et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A search database study
SJ Freedland et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
How to measure comorbidity: a critical review of available methods
V de Groot et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Share Paper
